Peng, N.-X., Liu, C.-X., Wang, X.-S., Zhang, Z.-J. and Liao, S.-C. (2015) “Combination of axitinib and dasatinib for anti-cancer activities in two prostate cancer cell lines”, Bangladesh Journal of Pharmacology, 11(1), pp. 130–137. doi: 10.3329/bjp.v11i1.24149.